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Interferons (IFN) ~ affect many cell functions in addition to their inhibitory 
action  on  virus  replication.  Among  these  effects  on  cell  functions  are  the 
inhibition of cell growth in vitro, augmentation or inhibition of natural  killer 
(NK) cell-mediated cytotoxicity, induction of major histocompatibility antigens, 
and the activation of macrophage-mediated cytotoxicity (reviewed in 1-3).  Dif- 
ferent  types  of IFN,  however,  may vary  in  their  capacities  to  mediate  these 
biological responses. For example, the mitogen-induced "immune" (gamma) IFN 
appears  to show stronger immunoregulatory (4-8)  and cell  growth inhibitory 
(9-11) activities than alpha or beta IFN. While recent studies used recombinant 
IFN-gamma (12) to demonstrate immunoregulatory activities of this IFN, most 
studies of antiproliferative activity used either crude or only partially purified 
IFN-gamma preparations,  thus leaving open the possibility that this biological 
activity may be at least partially due to the presence of other cytotoxic lympho- 
kines in these preparations. 
Lymphotoxins (LT) are a group of lymphocyte-derived glycoproteins possess- 
ing direct cytostatic and cytolytic activity for a  variety of tumor cells (reviewed 
in 13-15).  LT inhibit the growth of transformed cells more than that of normal 
cells from the same species (16,  17). In addition to their effects on cell growth, 
LT may play a role in cell-mediated immune reactions. LT has been implicated 
in cytolytic T  lymphocyte-mediated cytotoxicity (18,  19),  antibody-dependent, 
cell-mediated cytotoxicity (ADCC) (20), and NK cell cytotoxicity reactions (21- 
23). Diverse forms of LT with molecular weights ranging from 12,000 to 200,000 
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and  somewhat  different lytic capabilities  have been  separated  by gel  filtration 
(24,  25).  In addition  to LT, a  number of other cytotoxins, apparently derived 
from monocytes or macrophages, have been described (25-29).  Their relation- 
ship to classic  LT (which itself has not been fully defined in molecular terms) 
needs to be clarified. 
We  recently demonstrated  that  LT and  IFN-gamma  are induced in  parallel 
after various  forms of mitogenic stimulation  (30).  In  another  report  (31),  we 
demonstrated that crude IFN-gamma preparations produced by human periph- 
eral blood leukocytes (PBL) upon stimulation  with  12-O-tetradecanoylphorbol- 
13-acetate (TPA) and phytohemagglutinin (PHA) exert a marked growth-inhib- 
iting effect on  HeLa cells and  human  foreskin  fibroblasts (FS-4) that  was  not 
observed with more highly purified IFN-gamma preparations (31). The present 
study was  undertaken  to determine whether LT and/or  other cytotoxins pro- 
duced along with IFN-gamma contribute to the cytotoxic activity of crude IFN- 
gamma preparations. 
Materials and  Methods 
Materials.  Plateletpheresis residues were obtained through the courtesy of M. Wiebe 
from the New York Blood Center. TPA (LC Services Corp., Woburn, MA) was dissolved 
in 100% ethanol at a concentration of 1 mg/ml and stored at -20°C. PHA was prepared 
in  the  laboratory of J.  D.  Oppenheim at New York University Medical Center; stock 
solutions at 1 or 10 mg/ml in phosphate-buffered saline (PBS), pH 7.4, were kept frozen 
at -20°C.  RPMI  1640 and  Eagle's minimal essential medium (MEM)  were purchased 
from Gibco Laboratories, Grand Island, NY. Silicic acid (SA) (100 mesh) was obtained 
from Mallinckrodt Inc., St. Louis, MO. Concanavalin A (Con A)-Sepharose 4B, DEAE- 
Sephacel, and AH-Sepharose were purchased from Pharmacia Fine Chemicals, Piscataway, 
NJ. Biogel P200 was obtained from Bio-Rad Laboratories, Rockville Center, NY. Pansor- 
bin,  a  preparation  of the  Cowan  I  strain  of Staphylococcus aureus, was  obtained from 
Calbiochem-Behring Corp.,  San  Diego,  CA.  Rabbit  antiserum  against  mouse  Ig  was 
purchased  from Cappel  Laboratories, Cochranville, PA.  Highly purified recombinant 
IFN-gamma from E. coli (recIFN-gamma) was prepared by Genentech, Inc., South San 
Francisco, CA; the specific activity of this material ranged from ~ 106 to 107 laboratory 
units/xng  of protein,  depending  on  the  assay  system  used.  IFN-alpha  purified on  a 
monoclonal antibody affinity column to a specific activity of 2 x  l0  s IU/mg of protein 
was a gift from Bernard Horowitz of the New York Blood Center. IFN-beta was prepared 
by Rentschler Arzneimittel, Laupheim, Federal Republic of Germany and further purified 
in this laboratory on Blue-Sepharose to a specific activity of ~107 IU/mg of protein. All 
other chemicals were of the highest purity grade from standard sources. 
Preparation of Conditioned Medium Containing IFN-gamma and Lymphotoxin.  The proce- 
dure for obtaining high yields of IFN-gamma by combined stimulation of human PBL 
with the tumor-promoting agent, TPA, and the T  cell mitogen, PHA, has been described 
(32). Briefly, plateletpheresis residues were washed once to remove plasma and seeded at 
a density of 6 x  106 white blood cells/ml in serum-free RPMI 1640 medium supplemented 
with gentamycin (50 #g/ml), Hepes (6 raM), Tricine (3 mM), and 20 ng/ml TPA. After 
a 2-3 h incubation period at 37°C in a humidified CO~ incubator, PHA was added to a 
final concentration of 5 ~g/ml and the cultures were incubated for an additional 48-72 
h, at which time the conditioned medium was harvested, centrifuged to remove cells and 
debris, and stored at 4°C until further processing. 
Isolation of Nonadherent and Adherent Cells.  Lymphocyte-rich plateletpheresis residues 
or buffy coats obtained from the New York Blood Center and from New York University 
Medical Center Blood Bank,  respectively, were  used for these studies within  24 h  of 
collection. The heparinized blood concentrates were diluted twofold with RPMI  1640 
medium  and  the  initial  separation  of leukocytes from  erythrocytes was  achieved  by 830  HUMAN  INTERFERON-GAMMA  AND  CYTOTOXINS 
centrifugation on Ficoll-Hypaque gradients at 400 g  for 30  min.  Cells collected at the 
interface were washed twice with serum-free RPMI  1640 and were subsequently resus- 
pended in RPMI  1640 containing  10% fetal bovine serum (FBS).  Removal of adherent 
cells was accomplished according to the method of Kumagai et al. (33).  Tissue culture 
flasks (175 cm  *) previously coated for 2 h with heat-inactivated FBS and washed once to 
remove serum were seeded with 50 ml of a white blood cell suspension adjusted to 4  x 
108 cells/ml and incubated for 1.5 h at 37°C in a CO~ incubator. The remainder of the 
FicolI-Hypaque-purified cells was set aside to be used as the "total" cell population. After 
the incubation period, nonadberent cells were removed and incubated in a second set of 
FBS-treated flasks for an additional  1.5 h. The nonadherent cells from the second set of 
flasks were collected and used in experiments as "nonadberent cells".  Firmly adherent 
cells from both sets of FBS-treated flasks were detached after incubation with Ca  +*, Mg  ++- 
free PBS, pH 7.4, containing 0.2%  EDTA and 5% FBS for 30 min at 37°C.  Adherent 
cells recovered after this procedure, which represented  10-20% of the total number of 
mononuclear cells present in the original unseparated cell population, were washed twice 
with serum-free RPMI  1640 to remove EDTA and serum. Populations of nonadherent, 
adherent, and total cells seeded in 24-well Linbro plates at a final cell concentration of 6 
x  108  cells/mi  were  treated  with  TPA  (20  ng/ml)  or  PHA  (5  ~g/ml),  alone  or  in 
combination, as described in the preceding section. Ceil-free supernatants were harvested 
at 72 h and assayed for both IFN-gamma and LT activities. 
Assay for IFN Activity.  The antiviral activity of IFN-gamma was assayed by inhibition 
of the cytopathic effect of encephalomyocarditis virus in human FS-4 fibroblasts in 96- 
well microtiter tissue culture plates as described elsewhere (32). An internal laboratory 
standard of human IFN-gamma was included in each assay and titers of IFN-gamma were 
expressed in laboratory units. 
Assay  for Lymphotoxin Activity.  This assay is a modification of that developed by Spofford 
et al. (34).  Briefly, L 999 cells (alpha subline, obtained from Gale Granger, University of 
California at Irvine, CA) were seeded at a density of 104 cells/well in 96-well plastic tissue 
culture plates in RPMI  1640 medium containing 3% FBS in the presence of 0.5 ug/ml 
mitomycin C. After a  16-24 h incubation period at 37°C in a humidified CO2 incubator, 
twofold serial  dilutions  of the  test  samples were  prepared  in  separate  96-well  plates. 
Mitomycin C-containing media from L 929 cell cultures were then discarded and replaced 
with the dilutions of the test samples. After a second incubation period of 24-48 h, the 
plates  were  examined  microscopically for  LT-induced  cytotoxiCity (rounding-up  and 
detachment of cells).  The highest dilution producing 50% cytotoxicity was taken as the 
endpoint of LT activity. LT activity is expressed in U/ml based on a laboratory standard 
provided by Gale Granger, as well as on an internal laboratory standard.  Human IFN- 
gamma (natural or recombinant) neither mimicked LT activity nor did it affect the action 
of LT in this assay using murine cells.  TPA and  PHA, at concentrations used for the 
induction of PBL cultures, were also without effect in the LT assay. 
HeLa Cell Clonal Survival Assay.  A cloned HeLa cell line was used. Cells were seeded 
in triplicate at a density of 100 cells per well in 24-well Linbro plates or 300 cells per 60- 
mm petri dish, in MEM supplemented with 5% FBS, gentamycin, fungizone, and Hepes. 
After allowing a minimum incubation period of 4 h for cell attachment, test samples of 
different IFN-gamma and LT preparations were added and the plates were returned to 
the incubator for a  period of 1 wk or until colonies were visible macroscopically. The 
colonies  were  washed  with  PBS,  fixed  with  methanol,  stained  with  Giemsa  staining 
solution, and the number of surviving colonies was scored. 
Partial Purification  of lFN-gamma and Lymphotoxin.  The three-step purification proce- 
dure developed in our laboratory for human  IFN-gamma has been described in detail 
elsewhere (35,  36). This procedure includes sequential adsorption and elution of condi- 
tioned medium on SA, Con A-Sepharose, and DEAE-Sephacel. The processed material 
was then concentrated by a Millipore CX-10 ultrafiltration unit (Millipore Corp., Bedford, 
MA). 
Gel Filtration  Chromatography.  Further purification of IFN-gamma and  LT was per- 
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sample of concentrated material purified by the three-step process was applied to a Biogel 
P200 column (1.5 X 86 cm) that was previously equilibrated with 20 mM sodium phosphate 
buffer, pH 8.0. The flow rate was adjusted to 20 ml/h and 0.5-ml fractions were collected 
and assayed for biological activity. 
Sodium Dodecyl Sulfate-Polyaerylamide Gel Electrophoresis (SDS-PAGE).  Electrophoresis 
was  performed on a  linear  10-20%  acrylamide gradient  slab  gel  using  the  Laemmli 
procedure (37). Samples used for electrophoresis were purified as described above and 
concentrated. For treatment with sodium dodecyl sulfate (NaDodSO4), sample solutions 
were adjusted to contain 0.1% of the detergent and were incubated for 10-30 min at 
25°C before application to the gel. Upon completion of electrophoresis, the slab was cut 
into l°mm slices with the aid of a razor blade gel slicer. About ¾ portions of each slice 
were used for assays of IFN-gamma and LT, and  1A  of each slice still attached to the 
molecular weight markers (low  molecular weight markers;  Bio-Rad Laboratories) was 
used for staining with Coomassie blue stain. 
Isoelectric Focusing.  Conditioned  medium  from TPA-PHA-stimulated  PBL  cultures 
containing both IFN and LT activities was processed through the DEAE-Sephacel step 
(see above), concentrated, and loaded into the middle portion of a glass cylindrical tube 
gel  (2  ×  110  mm)  containing  7.5%  acrylamide plus  0.2%  ampholine (pH  3.5-10.0). 
Glycerol concentrations in the bottom, middle, and top portions of the gel were 15, 11.5, 
and 6.5%, respectively. Electrophoresis was performed at 500 V for 3-4 h at 4°C. After 
electrophoresis, extruded gels were frozen at -70°C and then separated into l-ram slices 
with a razor blade gel slicer. Each gel slice was eluted overnight at 4°C in 1 ml of MEM 
containing 5% FBS, and assayed the following day for LT and IFN-gamma activities. For 
pH determinations, two 1-mm slices were placed in 1 ml of degassed H~O and allowed to 
equilibrate for 1 h at 4°C before taking pH readings. 
Fast Protein Liquid Chromatography (FPLC).  Conditioned medium containing both lym- 
phokine activities was processed through the Biogel P200 step, concentrated, and further 
purified by FPLC separation, performed by Larry Schwartz at the Pharmacia Applications 
Laboratory, Piscataway, NJ. The sample, equilibrated with 20 mM Tris-HCI, pH 7.0, was 
first chromatographed on a  Mono Q  (anionic) exchanger (Pharmacia Fine Chemicals). 
The unbound flow-through fraction containing close to 100% of the LT and IFN-gamma 
activities present in the starting material was subsequently chromatographed on a Mono 
S (cationic) exchanger. Elution in both cases was with a linear salt gradient ranging from 
0 to 0.5 M NaCl in 20 mM Tris-HCl. Final elution was with 1 M NaC1. Fractions of 0.5 
ml were collected, diluted  1:10 in  MEM with  5%  FBS,  and assayed for LT and IFN- 
gamma activities. 
Neutralization  of IFN-gamma and  Lymphotoxin by Antisera.  Appropriate  dilutions  of 
supernatants from TPA-PHA-induced PBL cultures, partially purified through the DEAE- 
Sephacel or Biogel P200 steps, were incubated with polyclonal antisera against human 
IFN-gamma  or  LT  for  1  h  at  37°C.  Residual  IFN-gamma  or  LT activity was  then 
determined by biological assays. Control samples included the lymphokine preparation or 
antiserum alone treated in a similar manner. Antibody titers are expressed in neutralizing 
units/ml, i.e., reciprocals of the highest dilution that completely neutralized 10 U/ml of 
IFN-gamma or LT. The antisera used in the experiments shown in Table II were as 
follows: (a) Rabbit anti-IFN-gammap~,~llypu,~ was prepared at NYU against partially puri- 
fied preparations of IFN-gamma that also contained LT activity (processed through the 
DEAE-Sephacel step).  It  had  a  neutralizing titer of 2,000  U/ml  for IFN-gamma.  (b) 
Rabbit anti-IFN-gammapu,~  was  prepared at  NYU  against  IFN-gamma  extracted from 
SDS-PAGE gel  slices  corresponding to  the  20,000  tool wt  species  of IFN-gamma  as 
previously described (31). The neutralizing titer was 200 U/ml for IFN-gamma. (c) Rabbit 
anti LTws was prepared against unfractionated whole supernatants (WS) of PHA-stimu- 
lated human PBL by the laboratory of Gale Granger, University of California at Irvine, 
CA (25). According to the producing laboratory, 2 #I neutralized 1 U/ml of LT activity. 
(d) Goat anti-LTa~,~.2 was prepared against the "alpha-2" subclass  of LT purified from 
PHA-stimulated human PBL after Ultragel, DEAE-Cellulose, and native PAGE (18) by 
Gale Granger's laboratory. 1 ~1 neutralized 1 U/ml of homologous LT activity. (e) Rabbit 832  HUMAN  INTERFERON-GAMMA  AND  CYTOTOXINS 
anti-LT~TsS was prepared agaist human LT purified from human iymphoblastoid 1788 
cells at Genentech, Inc. The titer of this antiserum measured with homologous LT was 
~7,500 neutralizing U/ml. 
Preparation of  Highly Purified Lymphotoxin by Use of Affinity Chromatography  with Monoclonal 
Antibody to IFN-gamma.  An  affinity column was prepared  using a  recently described 
monoclonal antibody (MAb)  to IFN-gamma (38).  An AH-Sepharose mini-column (bed 
volume, 5 ml) equilibrated with PBS was activated by very slowly pumping 10 ml of 12.5% 
glutaraldehyde (vol/vol in PBS) through the column for a period of 1 h. Excess glutaral- 
dehyde was  removed  by several  washes with  PBS.  7  ml  of hybridoma culture  fluid 
containing enough MAb to neutralize 35,000-70,000 U of human IFN-gamma activity 
was carefully pumped onto the column and recycled a total of three times over a period 
of 2 h. The column was washed with PBS until no more protein was detectable in the 
eluate. The column was then washed with  10 vol of 0.1  M ethanolamine in PBS and 
equilibrated with 10 vol of PBS. A partially purified preparation of IFN-gamma and LT 
processed through the Con A-Sepharose step was slowly added onto this column and the 
flow-through material was assayed for both lymphokine activities. 
lmmunoprecipitation of IFN-gamma Using MAb to Human IFN-gamma.  Two hybridomas 
secreting MAb to human IFN-gamma were recently preared by Le et al. (39).  B3  is a 
cloned mouse hybridoma that secretes a neutralizing MAb with titers of ~ 1,000  U/ml in 
tissue culture supernatants and  1 X 108 U/ml in ascites fluid. Another hybridoma, B1, 
secretes a  nonneutralizing MAb that binds human IFN-gamma with high avidity. The 
procedure for immunoprecipitation was briefly as follows: a  100 ~1 aliquot of either B3 
or B1 hybridoma supernatant was incubated for 90 min at 37°C with 100 tA of partially 
purified conditioned medium sequentially processed through the DEAE-Sephacel  step. A 
100 ~i aliquot of rabbit antiserum to mouse Ig (24 t~g/ml) was added and the mixture 
was further incubated for 30 min. Finally 100 tA of washed Pansorbin was added and the 
mixture was incubated for another 50 min. The immunoprecipitate was sedimented by 
centrifugation in a Beckman microcentrifuge (Beckman Instruments, Inc., Fullerton, CA) 
for 2 min. The supernatants were then assayed for LT and IFN-gamma activities. 
Results 
Inhibitory Effects of Different IFN Preparations  in  the HeLa Cell Clonal  Survival 
Assay.  To evaluate the relative potencies of various IFN, we compared prepa- 
rations of IFN-gamma of increasing purity,  including highly purified recIFN- 
gamma, with purified preparations of IFN-alpha and IFN-beta in their effects 
on HeLa cell clonal survival (Fig. 1). Crude IFN-gamma preparations from TPA- 
PHA-induced PBL supernatants showed the strongest dose-related inhibition of 
clonal survival, while highly purified recombinant IFN-gamma, as well as natural 
IFN-alpha and beta, showed none.  IFN-gamma partially purified by sequential 
adsorption and elution on SA, Con A-Sepharose, and DEAE-Sephacei  showed 
intermediate activity. The inhibitory action of the crude and partially purified 
IFN-gamma was not due to extraneous agents used for induction, such as TPA 
and PHA, or to chemicals introduced during the purification procedures (data 
not shown). These results imply that a factor different from IFN-gamma present 
in these preparations is responsible for the potent cytotoxic effect in the HeLa 
cell clonal survival assay used in our experiments. 
We recently reported (30) that high levels of other lymphokines including LT 
are induced in plateletpheresis-derived PBL cultures after stimulation with TPA 
and  PHA.  It  was,  therefore,  conceivable  that  LT or some  unidentified cyto- 
toxin(s) might play a  role in the cytotoxic effect of crude and partially purified 
IFN-gamma preparations demonstrated in the HeLa cell clonal survival assay. 
Cytotoxin Production by Various Cell Populations Present in PBL.  To determine STONE-WOLFF ET  AL.  833 
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FIGURE  1.  Comparative effects of human IFN on HeLa cell clonal survival. The HeLa cell 
clonal survival assay is described in Materials and Methods. Cells were seeded in 60-mm dishes 
in triplicate per condition.  After cell attachment, the appropriate IFN preparation was added 
to the cultures at different concentrations. Crude IFN-gamma (O) was a 72-h supernatant 
collected from cultures of  plateletpheresis  residue cells stimulated with TPA and PHA. Partially 
purified IFN-gamma (tD) was a preparation processed  sequentially  on SA, Con A-Sepharose, 
and DEAE-Sephacel.  ReclFN-gamma (0), IFN-alpha (A), and IFN-beta (12]) are described in 
Materials and Methods. Activities of IFN-alpha and -beta are expressed  in international  units, 
while the potency of IFN-gamma is expressed  in ~laboratory units." 
TABLE  I 
Induction of "Lymphotoxin" Activities in Unseparated or Fractionated Human PBL Cultures* 
Source of PBL cells  Treatment 
Nonadherent  Adherent 
Total cells  cells  cells 
IFN-  IFN-  IFN-  LT  LT  LT  gamma  gamma  gamma 
Buff}, coat 
Plateletpheresis  residue 
U/ml 
None  <4  <2  <4  <2  <4  <2 
PHA 5 t~g/ml  12  16  64  96  <4  <2 
TPA 20 ng/ml  <4  4  24  8  <4  128 
TPA and PHA  320  96  4,096  1,024  64  96 
None  <4  4  <4  <2  <4  <2 
PHA 5 #g/ml  16  4  512  56  <4  <2 
TPA 20 ng/ml  192  32  96  24  <4  512 
TPAand PHA  10,240  640  7,680  800  512  512 
* Details of procedure are described in Materials and Methods. 
which cell population was producing LT activity in these cultures, plateletpheresis 
residue or buffy coat-derived mononuclear leukocytes were separated  into non- 
adherent and adherent  cell subpopulations.  Cultures seeded with cells from the 
interface of Ficoll-Hypaque gradients (total cells), and cultures seeded with similar 
numbers of nonadherent  or adherent cells, were stimulated with either TPA  (20 
ng/ml) or PHA (5 ug/ml) alone, or by combined treatment with TPA and PHA. 
IFN-gamma  and  LT  activities  were  determined  in  culture  supernatants.  The 
results  of two  representative  experiments  with  cultures  of PBL  derived  from 
pooled buffy coats or a  plateletpheresis  residue are shown in Table I. 
In agreement with earlier findings (30), unseparated  PBL cells stimulated with 
PHA  or  TPA  alone  produced  low  yields  of IFN-gamma  and  LT.  Combined 
treatment  with  TPA  and  PHA  produced  a  synergistic  enhancement  in  the 
production of both lymphokine activities which was particularly marked in total 834  HUMAN INTERFERON-GAMMA AND CYTOTOXINS 
cells derived from the plateletpheresis residue. It was noted earlier that cultures 
from buffy coats generally produce lower yields of IFN-gamma than cells from 
plateletpheresis residues (32).  Nonadherent cells from bully coats were more 
responsive to all  inducing treatments; nonadherent cells from plateletpheresis 
residues were more responsive to PHA and about equally responsive to the other 
inducing treatments as total  cells. These results suggest that adherent cells in 
some instances suppress IFN-gamma and LT induction, but this conclusion and 
the  exact nature  of the  putative  suppressor  cell  will  have  to  be  clarified in 
reconstitution experiments. 
A clear dissociation between the appearance of IFN-gamma and LT activities 
occurred in the adherent ceils. IFN-gamma production was detectable only after 
combined stimulation with TPA and PHA; since the yields were relatively low, 
it is possible that IFN-gamma in these cultures was produced by residual nonad- 
herent cells that  were not removed during the cell separation procedure.  In 
contrast, LT activity was induced in the adherent cells with TPA alone and no 
further increase in this activity occurred after the addition of PHA. These results 
suggested that two types of cytotoxic factors, indistinguishable in the LT assay, 
might be produced in PBL cultures. 
This conclusion was also supported by immunological evidence. A polyclonal 
rabbit antiserum prepared against highly purified LT from a human B lympho- 
blastoid cell line, RPMI  1788 (40), neutralized LT activity produced by nonad- 
herent cells in response to PHA treatment whereas cytotoxic activity produced 
by adherent cells or total cells in response to TPA treatment alone was barely 
neutralized. Supernatants from total cells treated with TPA and PHA were only 
partially neutralized by this antiserum (results not shown). 
Attempts  to Separate IFN-gamma from Cytotoxins by Physicochemical Methods.  A 
procedure designed for the partial purification of IFN-gamma (35, 36) was used 
in an attempt to separate IFN-gamma and LT activities present in the superna- 
tants of unseparated (total) PBL cultures stimulated by combined treatment with 
TPA and PHA. The two activities could not be separated in the first two steps 
of this procedure consisting of sequential adsorption and elution on SA and Con 
A-Sepharose (data not shown). Both activities adsorbed completely to SA and 
were quantitatively recovered in fractions eluted with 50%  ethylene glycol. 80 
and 60%  of IFN-gamma and LT activities, respectively, were recovered in the 
fractions eluted from Con A-Sepharose with alpha-methyl-D-mannopyranoside. 
IFN-gamma and LT activity-containing fractions, eluted from Con A-Sepha- 
rose and equilibrated by dialysis against 20 mM sodium phosphate buffer, pH 
8.2, were then applied to DEAE-Sephacel ion exchange columns and eluted with 
an  NaC!  gradient.  Both  LT and  IFN-gamma activities were recovered in the 
unbound  fraction  and  neither  one  of the  two activities  was  recovered upon 
elution of the column with salt gradients ranging from 0.1  to 0.5 M NaCI (data 
not shown). To determine the isoelectric points of the proteins responsible for 
the two activities more accurately, we applied concentrated, partially purified 
preparations into the middle of an isoelectric focusing gel with a  pH gradient 
ranging from 3.5  to  10.0  and analyzed the resulting fractions for both  IFN- 
gamma and LT activities. Both lymphokines were heterogeneous with respect to 
charge. The major component of LT activity focused at a pH of 7.6, with minor STONE-WOLFF  ET  AL.  835 
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FIOUaE  2.  Partial separation of LT (  ) and IFN-gamma (- -  -) activities by gel filtration 
on Biogel P200. The sample loaded onto the column was sequentially processed through the 
DEAE-Sephacel step and then concentrated ~ 10-fold with a Millipore uhrafihration unit. 
components ranging in pI from 6.8 to 8.8. The two major peaks of IFN-gamma 
activity focused at pH 9.2 and 8.5, with minor components overlapping the pH 
range of LT activity (data not shown). Even the high resolving power of FPLC 
could not separate  the  IFN-gamma and  LT activities.  Elution of the  Mono S 
cationic exchanger column resulted in the separation of several distinct protein 
peaks. Although the ratios of the two biological activities present in the eluted 
fractions  varied,  IFN-gamma and  LT  activities overlapped  (data  not  shown). 
Thus, we were unable to separate these two activities completely on the basis of 
charge either by isoelectric focusing or by FPLC. 
To determine whether IFN-gamma and LT activities could be separated by 
molecular size, a sample of partially purified conditioned medium was subjected 
to molecular sieve chromatography using a  Biogel P200  column (Fig.  2).  LT 
activity chromatographed in one major peak at 58,000 moi wt, while IFN-gamma 
activity chromatographed at a molecular weight corresponding to 50,000. How- 
ever, when the same material was treated with 0.1%  NaDodSO4 and subjected 
to SDS-PAGE, LT activity eluted in two peaks (Fig. 3), a major peak at 60,000 
mol wt and a  minor peak at  20,000  mol wt.  This 20,000  mol wt activity, not 
seen in the absence of denaturing treatment on Biogel P200, coeluted from the 
same  1-mm gel slice with the 20,000 mol wt monomer of IFN-gamma activity. 
However, the 25,000 mol wt monomer and undissociated dimer of IFN-gamma 
could be separated from the 60,000 tool wt form of LT, which might represent 
an oligomeric form (40).  Data summarized in the legend of Fig.  3 also reveal 
that LT activity is more stable than IFN-gamma upon NaDodSO4 treatment. 
Immunological Characterization and  Separation  of LT  and  IFN-gamma  Activi- 
ties.  Cytotoxic activity present in unprocessed conditioned medium could not 
be  completely neutralized  by  antiserum  to  highly purified  LT  derived  from 
RPMI 1788 cells (not shown). However, after sequential purification on SA, Con 
A-Sepharose, and DEAE-Sephacel, all cytotoxic activity was neutralized by this 
antiserum as well as by sera prepared against  LT from human tonsillar tissue 
(25).  These  results  (Table  II)  imply  that  a  non-LT  cytotoxin present  in  the 
original  crude  preparations  was  separated  from  LT  during  the  purification 
procedure. None of the anti-LT sera neutralized IFN-gamma activity, and LT 836  HUMAN  INTERFERON-GAMMA  AND  CYTOTOXINS 
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sample of conditioned medium processed through the Biogel P200 step was adjusted to contain 
0.1% NaDodSO4 and incubated for  10 min at room temperature before application to the 
gel. This sample originally  contained a total of 3,840 U of LT activity and 336,000 U of IFN- 
gamma activity. After NaDodSO4 treatment, the total LT activity was reduced by 20% to 
3,072 U while IFN-gamma activity was reduced by 81.7% to 61,440 U. The final recoveries 
of LT and IFN-gamma activities after SDS-PAGE were 53.5 and 7.6% of the amounts applied 
onto the gels, respectively. 
TABLE  II 
Effect of Antisera Against IFN-gamma or LT on Antiviral or Cytotoxic 
Activities  of Partially Purified Lymphokine Preparations 
Lyre-  Units/ml 
phokine  Antisera added* 
prepa-  IFN-  LT 
ration*  gamma 
1  None  77  51 
Rabbit anti-IFN-gamma0,~lyp=re  <4  <2 
None  1,024  64 
Rabbit anti-LTl~ss  768  <2 
Rabbit anti-IFN-gammap,~  <4  64 
None  2,048  64 
Rabbit anti-LTws  2,048  <2 
Goat anti-LT=l~a  1,024  <2 
* Lymphokine preparations were  obtained from  TPA-PHA-stimulated 
supernatants of unfractionated PBL cultures derived from plateletpher- 
esis residues. Preparations 1 and 2 were partially purified by sequential 
processing on SA, Con A-Sepharose, and DEAE-Sephacel. Preparation 
3 was purified in the same way as preparations 1 and 2 except that the 
Biogel P200 step was added. 
* Neutralization assays  were  performed  as  described  in  Materials and 
Methods. STONE-WOLFF  ET  AL. 
TABLE  III 
Separation of LT and IFN-gamma by lmmunoprecipitation with 
Monoclonal Antibodies to IFN-gamma 
Monoclonal anti-  Staphylococcus 
body added*  aureus cells 
Units/ml 
IFN-gamma  LT 
None  -  512  160 
B3  -  <4  128 
B1  -  512  192 
None  +  512  256 
B3  +  <4  256 
B1  +  <4  256 
* 100-#1 aliquots of HAT medium (RPMI  1640  medium supplemented 
with hypoxanthine, aminopterin, and thymidine; for formula, see 39), 
IFN-gamma-neutralizing  MAb  B3,  or  IFN-gamma-binding  MAb  B1 
were incubated for 90 min at 37°C with 100 #l of concentrated, partially 
purified,  TPA-PHA-induced conditioned  medium  (processed  sequen- 
tially through the DEAE-Sephacel step). A  100-#l aliquot of rabbit anti- 
mouse IgG (24 #g/ml) was added and the mixture was further incubated 
for 30 rain. Finally, 100 #1 of washed Staphylococcus  aureus Cowan strain 
1 (Pansorbin) was added as indicated and the mixtures were incubated 
for another 50 min at 37°C. PBS was added instead of Pansorbin to the 
appropriate groups. The immunoprecipitates were collected by centrif- 
ugation in a Beckman microcentrifuge for 2 rain. The supernatants were 
then assayed for LT and IFN-gamma activities. 
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activity, in turn, was not neutralized by antiserum prepared by immunization of 
a  rabbit  with highly purified natural  IFN-gamma isolated on SDS-PAGE (31). 
However, an antiserum prepared against less highly purified human IFN-gamma 
did neutralize both IFN-gamma and LT activities. We conclude that the major 
cytotoxin present in partially purified IFN-gamma preparations is immunologi- 
cally identical or closely related to  LT produced by human tonsillar tissue in 
response to Con A or PHA stimulation (25, 41) and to LT produced constitutively 
by RPMI  1788 cells (40). 
Selective Immunoprecipitation of  lFN-gamma with MAb.  Isolation of several mouse 
MAb specific for human IFN-gamma was recently described (38,  39).  One of 
these,  MAb B3,  neutralizes IFN-gamma activity, while another one, MAb B1, 
binds with high affinity to IFN-gamma without neutralizing its antiviral activity. 
However,  the addition of protein A-containing Staphylococcus aureus cells (Pan- 
sorbin) to IFN-gamma that had been reacted with MAb B1  was shown to result 
in the formation of a precipitate (39). 
In an attempt to selectively remove IFN-gamma, an aliquot of a  preparation 
containing IFN-gamma and LT was incubated with either MAb B1 or B3, with 
or without subsequent immunoprecipitation with the aid of Pansorbin. MAb B3 
neutralized all  IFN-gamma activity  without significantly affecting  LT  activity 
(Table III). Addition of MAb B1  did not neutralize either IFN-gamma or LT 
activities but did result in the removal of all IFN-gamma activity after immuno- 
precipitation. 
Synergistic  Inhibitory  Effect  of IFN-gamma  and  LT  on  HeLa  Cell  Clonal  Sur- 
vival.  Separation  of IFN-gamma  and  LT  with  the  aid  of the  MAb  to  IFN- 838  HUMAN  INTERFERON-GAMMA  AND  CYTOTOXINS 
TABLE  IV 
Synergistic Inhibitory Effect of Purified redFN-gamma and LT on 
HeLa Cell Clonal Survival* 
Percent control survival +  SD after addition of: 
ReclFN- 
gamma  LT units/ml 
(units/ml) 
None  4  16 
None  100.0  93.4 +  12.6  75.2 +  11.0 
16,384  90.1 +  8.3  33.7 ±  5.8  2.2 +  1.9 
* HeLa cells were  seeded in triplicate into a  24-well  Linbro plate at a 
concentration of 100 cells/well. After cell attachment (4 h), a dilution 
of recIFN-gamma was added  alone or  in combination with different 
dilutions of purified LT.  LT was purified by sequential processing of 
TPA-PHA-induced supernatants of PBL  cultures on  SA and Con  A- 
Sepharose.  IFN-gamma  was  removed  by  binding  to  an  IFN-gamma 
antibody affinity column consisting of a  neutralizing monoclonal IFN- 
gamma antibody bound to AH-Sepharose (see Materials and Methods). 
The fiow-through material from this affinity column, concentrated 10- 
fold, contained LT but no IFN-gamma activity. The average number of 
colonies in untreated control cultures (100% clonal survival) was 60.3 + 
3.7. 
gamma made it possible to address the question of whether the two lymphokines 
act synergistically in inhibiting the clonal growth of HeLa cells.  LT separated 
from IFN-gamma by a  MAb affinity column (Table  IV) was evaluated in  the 
HeLa cell clonal assay either alone or in combination with different concentra- 
tions of purified E.  coil-derived  reclFN-gamma (which contains no LT activity). 
A remarkable synergism was observed: although 16,384 U/ml of recIFN-gamma 
and  16  U/ml of LT by themselves produced no significant reductions in  the 
number of colonies, combined together they reduced the number of colonies by 
97.8%. 
Discussion 
Earlier we observed (31)  that  crude IFN-gamma preparations  produced by 
human PBL stimulated with TPA and PHA exert a  greater growth-inhibiting 
and cytotoxic effect on HeLa cells than highly purified IFN-gamma preparations 
(31).  In another report (30) we demonstrated that high levels of both LT and 
IFN-gamma activities were induced in  human  PBL  cultures after stimulation 
with TPA and PHA. These observations prompted us to determine what role 
LT  (and,  possibly,  some other cytotoxic proteins  present  in  the  crude  IFN- 
gamma preparations) might have in the cytotoxic activity. 
Experiments with fractionated PBL showed that the LT activity produced by 
combined treatment with TPA and PHA is a  mixture of at least two cytotoxic 
factors.  One  factor resembles classic  LT  in  that  it  is  produced primarily by 
lymphocytes (nonadherent cells) in response to PHA treatment, and it is neu- 
tralized by antiserum to a highly purified preparation of human RPMI 1788 cell 
line-derived LT and by antiserum to LT from tonsillar cells. The other factor is 
produced by adherent cells in response to TPA; its production is not enhanced 
by the addition of PHA and it is not neutralized by antiserum to LT from RPMI STONE-WOLFF  ET  AL.  839 
1788 cells. This cytotoxin from adherent cells might be related to tumor necrosis 
factor (TNF) (26, 27) and/or macrophage cytolytic factor (28). Crude superna- 
tants  from TPA-PHA-induced unseparated  PBL  cultures were only partially 
neutralized by anti-LTlTss, while supernatants processed through the three initial 
steps of the IFN-gamma purification scheme (SA, Con A-Sepharose, and DEAE- 
Sephacel) were totally neutralized by this antiserum, indicating that the adherent 
cell cytotoxic activity present in  the original  supernatant  was separated  from 
classic  LT during the purification. It has been reported that TNF binds to Con 
A-Sepharose (27),  while an endotoxin-induced monocyte cytolytic factor does 
not (29). Therefore, the cytotoxin(s) produced by adherent cells may have been 
separated from classic LT by Con A-Sepharose chromatography. 
Classic  LT activity shares many physicochemical properties with IFN-gamma 
and therefore separation of these two lymphokine activities by physicochemical 
methods  proved  difficult.  Other  investigators  (24,  25,  41)  have  reported  a 
separation of distinct molecular weight classes of LT from mitogen-induced PBL 
or tonsillar lymphocytes by gel filtration.  However, whether these various LT 
classes are aggregates derived from a single species has yet to be determined. In 
contrast, we find only one form of LT activity on gel filtration with a  58,000 
mol wt. Similarly, the isolation of only one form of RPMI  1788 cell LT, with a 
64,000  mol wt determined by gel filtration,  was reported (40).  Although LT 
activity produced by TPA-PHA induction had an apparent 58,000 mol wt upon 
gel filtration, two peaks were demonstrated on SDS-PAGE with apparent molec- 
ular weights of 60,000 and 20,000.  A similar dissociation of the 64,000 mol wt 
LT from RPMI 1788 cells into 25,000 and 20,000 mol wt monomers after SDS- 
PAGE treatment was described (42). It is, therefore, conceivable that native LT, 
like native IFNogamma (36), exist as aggregated glycoproteins which, after SDS 
treatment, partially dissociate into smaller molecular weight monomers. 
Since we  were unable  to  separate  LT  and  IFN-gamma activities,  we  were 
initially uncertain whether the two activities are due to distinct proteins. How- 
ever, immunologic studies in which an MAb to IFN-gamma removed the IFN- 
gamma activity but did not diminish the amount of LT activity present in the 
supernatant proved that these activities are due to two different proteins. This 
result gave us a means to physically separate these two lymphokines and to study 
their interactions with respect to  HeLa cell cytotoxicity. We showed a  potent 
synergistic effect on  cytotoxicity when purified  LT and recIFN-gamma were 
added together to a culture of HeLa cells. As little as 16 U/ml of LT added to 
16,384  U/ml of recIFN-gamma resulted in a 97.8%  reduction in survival over 
that observed with either lymphokine alone. Recent reports from other labora- 
tories also demonstrated a  synergistic enhancement of antiproliferative activity 
when recombinant IFN-alpha (43) as well as recombinant IFN-gamma (42) were 
used in combination with LT. 
It was recently reported (38) that HeLa cell cytotoxicity induced by prepara- 
tions of IFN-gamma was completely neutralized by an MAb to IFN-gamma. This 
finding is not contradictory to our results, since it is clear that in some cell lines 
IFN-gamma alone can be cytotoxic. For instance, a recent study  2 demonstrated 
Le, J., Y. K. Yip, and J. Vil~ek. Cytolytic activity of interferon-gamma and its synergism with 5- 
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that purified human reclFN-gamma (which contained no LT activity demonstra- 
ble in the L  929 assay) was cytotoxic for two out of six human cell lines tested 
(44).  This cytotoxicity of reclFN-gamma was abolished by the addition of an 
MAb that neutralizes IFN-gamma activity. 
Summary 
Crude preparations of interferon (IFN)-gamma derived from human periph- 
eral blood leukocyte (PBL) cultures induced with  12-O-tetra-decanoylphorbol- 
13-acetate (TPA) and phytohemagglutinin (PHA) were more cytotoxic to HeLa 
cells than partially purified nautral or highly purified recombinant human IFN- 
gamma preparations. Conditioned media from PBL cultures contained, in addi- 
tion to I FN-gamma, a mixture of cytotoxins, including classic lymphocyte-derived 
lymphotoxin (LT), and a  TPA-induced cytotoxic activity produced by the ad- 
herent cell population (presumably monocytes). These two types of cytotoxins, 
indistinguishable in the mouse L929 cell LT assay, could be differentiated by an 
antiserum prepared  against  LT  derived from the  B  iymphoblastoid cell  line 
RPMI 1788. This antiserum neutralized lymphocyte-derived  classic LT but failed 
to  neutralize  the  activity  of the  monocyte-derived cytotoxin.  Processing  of 
conditioned media by sequential chromatography on silicic acid, Con A-Sepha- 
rose, and DEAE-Sephacel failed to separate IFN-gamma from the LT activity. 
However, this procedure did remove the monocyte-derived cytotoxic activity 
present in the original starting material, leaving predominantly classic  LT. This 
LT showed a slightly basic isoelectric point (pI 7.6) which partially overlapped 
the more basic pI range of IFN-gamma. The two lymphokine activities also could 
not be completely separated by fast protein liquid chromatography or molecular 
sieve chromatography. LT in these partially purified preparations was associated 
with a protein having an apparent molecular weight of 58,000 on gel filtration. 
This form dissociated partially into a  20,000  mol wt species after denaturation 
with 0.1% NaDodSO4. IFN-gamma could be selectively removed from prepara- 
tions containing both IFN-gamma and LT with the aid of monoclonal antibody 
to IFN-gamma. The addition of purified LT to purified E.  coli-derived recom- 
binant  human  IFN-gamma  resulted  in  a  marked synergistic enhancement of 
cytotoxicity for HeLa cells. 
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